BR112013031570A2 - inalador de pó seco. - Google Patents
inalador de pó seco.Info
- Publication number
- BR112013031570A2 BR112013031570A2 BR112013031570A BR112013031570A BR112013031570A2 BR 112013031570 A2 BR112013031570 A2 BR 112013031570A2 BR 112013031570 A BR112013031570 A BR 112013031570A BR 112013031570 A BR112013031570 A BR 112013031570A BR 112013031570 A2 BR112013031570 A2 BR 112013031570A2
- Authority
- BR
- Brazil
- Prior art keywords
- dry powder
- powder inhaler
- inhaler
- dry
- powder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161494594P | 2011-06-08 | 2011-06-08 | |
PCT/EP2012/060442 WO2012168160A1 (en) | 2011-06-08 | 2012-06-01 | Dry powder inhaler compositions comprising umeclidinium |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013031570A2 true BR112013031570A2 (pt) | 2017-03-21 |
Family
ID=46201673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013031570A BR112013031570A2 (pt) | 2011-06-08 | 2012-06-01 | inalador de pó seco. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20140116434A1 (pt) |
EP (1) | EP2717867A1 (pt) |
JP (1) | JP2014518894A (pt) |
KR (1) | KR20140041700A (pt) |
CN (1) | CN103561731A (pt) |
AU (1) | AU2012266540A1 (pt) |
BR (1) | BR112013031570A2 (pt) |
CA (1) | CA2838031A1 (pt) |
RU (1) | RU2013153202A (pt) |
WO (1) | WO2012168160A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2400950B1 (en) | 2009-02-26 | 2019-05-22 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
RU2666963C2 (ru) | 2012-04-13 | 2018-09-13 | Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Агрегированные частицы |
GB201222679D0 (en) | 2012-12-17 | 2013-01-30 | Glaxo Group Ltd | Pharmaceutical combination products |
AU2015275933A1 (en) | 2014-06-18 | 2017-02-02 | Cipla Limited | Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent |
CN105461710A (zh) * | 2015-10-23 | 2016-04-06 | 安徽德信佳生物医药有限公司 | 一种芜地溴铵的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
AU2001275760B2 (en) | 2000-08-05 | 2005-03-17 | Glaxo Group Limited | 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent |
ATE417606T1 (de) | 2001-09-14 | 2009-01-15 | Glaxo Group Ltd | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege |
GB0201677D0 (en) | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
GB0217196D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
JP2007528414A (ja) * | 2004-03-11 | 2007-10-11 | セラヴァンス, インコーポレーテッド | ムスカリンレセプターアンタゴニストとしての有用なジフェニルメチル化合物 |
AR050902A1 (es) | 2004-04-27 | 2006-12-06 | Glaxo Group Ltd | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion |
GB0515584D0 (en) | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
AR058289A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Colector para ser usado en dispensador de medicamento |
AU2010258751A1 (en) * | 2009-06-09 | 2012-02-02 | Sunovion Respiratory Development Inc. | Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration |
GB0921075D0 (en) * | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
-
2012
- 2012-06-01 CN CN201280027634.5A patent/CN103561731A/zh active Pending
- 2012-06-01 EP EP12725046.2A patent/EP2717867A1/en not_active Withdrawn
- 2012-06-01 US US14/124,270 patent/US20140116434A1/en not_active Abandoned
- 2012-06-01 KR KR1020147000493A patent/KR20140041700A/ko not_active Application Discontinuation
- 2012-06-01 JP JP2014514007A patent/JP2014518894A/ja active Pending
- 2012-06-01 BR BR112013031570A patent/BR112013031570A2/pt not_active IP Right Cessation
- 2012-06-01 RU RU2013153202/15A patent/RU2013153202A/ru not_active Application Discontinuation
- 2012-06-01 AU AU2012266540A patent/AU2012266540A1/en not_active Abandoned
- 2012-06-01 WO PCT/EP2012/060442 patent/WO2012168160A1/en active Application Filing
- 2012-06-01 CA CA2838031A patent/CA2838031A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2014518894A (ja) | 2014-08-07 |
AU2012266540A1 (en) | 2014-01-09 |
KR20140041700A (ko) | 2014-04-04 |
RU2013153202A (ru) | 2015-07-20 |
CA2838031A1 (en) | 2012-12-13 |
EP2717867A1 (en) | 2014-04-16 |
WO2012168160A1 (en) | 2012-12-13 |
CN103561731A (zh) | 2014-02-05 |
US20140116434A1 (en) | 2014-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014004921A2 (pt) | dispositivo inalador de pó seco | |
BR112016011996A2 (pt) | inalador de pó seco | |
HK1204989A1 (en) | Inhalable dry powders | |
BR112013014958A2 (pt) | inalador de pó seco | |
BR112015004233A2 (pt) | inalador. | |
CO6801645A2 (es) | Nuevos inmunoconjugados | |
FR2962343B1 (fr) | Inhalateur de poudre seche. | |
FR2987609B1 (fr) | Moyens antiaffaissement | |
BR112014029111A2 (pt) | inalador | |
BR112015004230A2 (pt) | inalador. | |
FR2962338B1 (fr) | Inhalateur de poudre seche. | |
BR112013031572A2 (pt) | produto de combinação farmacêutica, e, inalador de pó seco. | |
FR2962342B1 (fr) | Inhalateur de poudre seche. | |
FR2962337B1 (fr) | Inhalateur de poudre seche. | |
BR112013031570A2 (pt) | inalador de pó seco. | |
DE102012213479B8 (de) | Positionsdetektor | |
FR2986872B1 (fr) | . | |
FR2977498B1 (fr) | Inhalateur de poudre seche. | |
CL2015001192A1 (es) | Composición herbicida | |
FR2962339B1 (fr) | Inhalateur de poudre seche. | |
BR112013032873A2 (pt) | arranjo de distribuição rotativo | |
BR112014001001A2 (pt) | pó de polímero | |
FR2978994B1 (fr) | . | |
DK2500470T3 (da) | Hoved-arbejdsvogn | |
FR2999560B1 (fr) | Poudre de cristallites |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |